Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,658,413
-$659,193 QoQ
Shares Held
68,360
-54.3% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 210 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. NRIX ranks #70 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in NRIX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,658,413 | 68,360 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,317,606 | 149,523 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,717,069 | 90,515 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $854,191 | 92,445 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $862,484 | 75,723 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,307,774 | 110,082 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,188,944 | 116,186 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,103,034 | 93,593 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,865,784 | 137,316 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,107,947 | 211,425 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $776,874 | 98,839 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,143,735 | 114,488 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,244,505 | 140,147 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,812,567 | 165,079 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,705,744 | 130,909 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $900,190 | 71,049 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,049,382 | 146,280 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,625,938 | 90,706 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,763,625 | 58,866 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,087,645 | 78,690 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,108,741 | 67,827 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||